|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07K 14/725 | (2006.01) |
| C07K 14/82 | (2006.01) |
| (11) | Patento numeris | 3494133 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17749580.1 |
| Europos patento paraiškos padavimo data | 2017-07-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-06-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-07-06 |
| (46) | Apibrėžties vertimo paskelbimo data | 2022-12-12 |
| (86) | Numeris | PCT/US2017/044615 |
| Data | 2017-07-31 |
| (87) | Numeris | WO 2018/026691 |
| Data | 2018-02-08 |
| (30) | Numeris | Data | Šalis |
| 201662369883 P | 2016-08-02 | US |
| (72) |
TRAN, Eric , US
LU, Yong-Chen , US
ROBBINS, Paul F. , US
ROSENBERG, Steven A. , US
ZHENG, Zhili , US
|
| (73) |
The U.S.A. as represented by the Secretary,
Department of Health and Human Services ,
Office of Technology Transfer
National Institutes of Health
6701 Rockledge Drive, Suite 700
MSC 7788, Bethesda, MD 20892-7788,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-KRAS-G12D T ląstelės receptoriai |
| ANTI-KRAS-G12D T CELL RECEPTORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-07-01 | 9 | 208.00 EUR |
| 2026-07-31 |